XML 23 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 245,197 $ 163,240
Investments in marketable securities 237,299 320,029
Accounts receivable 52,672 46,923
Inventories 26,818 19,556
Prepaid expenses and other current assets 34,848 29,721
Total current assets 596,834 579,469
Operating lease right-of-use assets, net 20,586 23,296
Property and equipment, less accumulated depreciation of $19,882 and $14,487 at December 31, 2021 and December 31, 2020, respectively 42,496 43,863
In-process research & development 23,000 23,000
Goodwill 197,797 197,797
Other non-current assets 24,427 19,095
Total Assets 905,140 886,520
Current liabilities:    
Accounts payable 21,513 17,063
Accrued expenses and other current liabilities 98,153 96,841
Contingent consideration payable 18,900 8,900
Operating lease liabilities 7,409 6,872
Total current liabilities 145,975 129,676
Deferred reimbursements 5,906 7,406
Long-term debt 389,357 389,254
Contingent consideration payable 1,439 16,925
Deferred income taxes 4,930 4,896
Operating lease liabilities 43,363 45,604
Other non-current liabilities 6,801 6,379
Total liabilities 597,771 600,140
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.01 par value, 500,000,000 shares authorized, 278,912,800 and 262,063,461 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 2,808 2,650
Additional paid-in capital 2,595,419 2,308,578
Accumulated other comprehensive gain (loss):    
Foreign currency translation adjustment 5,251 8,412
Unrealized loss on available-for securities (270) (185)
Warrants 83 12,387
Accumulated deficit (2,295,922) (2,045,462)
Total stockholders' equity 307,369 286,380
Total Liabilities and Stockholders' Equity $ 905,140 $ 886,520